Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice

Stem Cells Translational Medicine

Volumn 4, Issue 6, 2015, Pages 615-624

  Cruz, Fernanda F ^a,b   Borg, Zachary D ^a   Goodwin, Meagan ^a   Sokocevic, Dino ^a   Wagner, Darcy ^a   McKenna, David H ^c   Rocco, Patricia R M ^b   Weiss, Daniel J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Asthma; Cryopreservation; Mesenchymal stromal cells; Mouse

Indexed keywords

BONE MARROW DERIVED MESENCHYMAL STEM CELL EXTRACT; CELL EXTRACT; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; RANTES; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL CULTURE; CONTROLLED STUDY; FREEZE THAWING; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG FIBROBLAST; LUNG FUNCTION; LUNG LAVAGE; MALE; MEDIASTINUM LYMPH NODE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PNEUMONIA; TH17 CELL; TH2 CELL; ANIMAL; ASTHMA; BONE MARROW CELL; CHEMICALLY INDUCED; CRYOPRESERVATION; DISEASE MODEL; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATHOLOGY; XENOGRAFT;

ASPERGILLUS; MURINAE; MUS;

ANIMALS; ASTHMA; BONE MARROW CELLS; CRYOPRESERVATION; DISEASE MODELS, ANIMAL; HETEROGRAFTS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; TH17 CELLS; TH2 CELLS;

EID: 84930510460     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0268     Document Type: Article

References (48)

1. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 2012;12: 383–396.
2. Keating A. Mesenchymal stromal cells: New directions. Cell Stem Cell 2012;10:709–716.
3. Bernardo ME, Fibbe WE. Mesenchymal stromal cells: Sensors and switchers of inflammation. Cell Stem Cell 2013;13:392–402.
4. Bianco P, Cao X, Frenette PS et al. The meaning, the sense and the significance: Translating the scienceofmesenchymal stem cells into medicine. Nat Med 2013;19:35–42.
5. Lalu MM, McIntyre L, Pugliese C et al. Safety of cell therapy with mesenchymal stro-mal cells (SafeCell): A systematic review and meta-analysis of clinical trials. PLoS One 2012; 7:e47559.
6. von Bahr L, Sundberg B, Lönnies L et al. Long-term complications, immunologic effects, androleofpassage foroutcomeinmesenchymal stromal cell therapy. Biol Blood Marrow Transplant 2012;18:557–564.
7. Cyranoski D. Canada approves stem cell product. Nat Biotechnol 2012;30:571.
8. Krampera M, Galipeau J, Shi Y et al. Immu-nological characterization of multipotent mes-enchymal stromal cells–the International Society for Cellular Therapy (ISCT) working proposal. Cytotherapy 2013;15:1054–1061.
9. Menard C, Pacelli L, Bassi G et al. Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: Standardization of immune quality controls. Stem Cells Dev 2013;22:1789–1801.
10. Viswanathan S, Keating A, Deans R et al. Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. Stem Cells Dev 2014;23:1157–1167.
11. Fong CY, Subramanian A, Biswas A et al. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton’s jelly stem cells. Reprod Biomed Online 2010;21: 391–401.
12. Eini F, Foroutan T, Bidadkosh A. The effects of freeze/thawing process on cryopre-served equine umbilical cord blood-derived mesenchymal stem cells. Comp Clin Pathol 2012;21:1713–1718.
13. Naaldijk Y, Staude M, Fedorova V et al. Effect of different freezing rates during cryopreservation of rat mesenchymal stem cells using combinations of hydroxyethyl starch and dimethylsulfoxide. BMC Biotechnol 2012;12:49.
14. Ginis I, Grinblat B, Shirvan MH. Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypother-mic storageinclinicallysafe medium. TissueEng Part C Methods 2012;18:453–463.
15. François M, Copland IB, Yuan S et al. Cry-opreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-g licensing. Cytotherapy 2012;14: 147–152.
16. Moll G, Alm JJ, Davies LC et al. Do cryo-preserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells 2014;32:2430–2442.
17. Cho KS, Park HK, Park HY et al. IFATS collection: Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Stem Cells 2009;27:259–265.
18. Cho KS, Roh HJ. Immunomodulatory effects of adipose-derived stem cells in airway allergic diseases. Curr Stem Cell Res Ther 2010; 5:111–115.
19. Bonfield TL, Koloze M, Lennon DP et al. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ov-albumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010;299:L760–L770.
20. Park HK, Cho KS, Park HY et al. Adipose-derived stromal cells inhibit allergic airway inflammation in mice. Stem Cells Dev 2010;19: 1811–1818.
21. Nemeth K, Keane-Myers A, Brown JM et al. Bone marrow stromal cells use TGF-beta to suppress allergic responsesinamouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 2010;107:5652–5657.
22. Firinci F, Karaman M, Baran Y et al. Mes-enchymal stem cells ameliorate the histopatho-logical changes in a murine model of chronic asthma. Int Immunopharmacol 2011;11:1120–1126.
23. Goodwin M, Sueblinvong V, Eisenhauer P et al. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells 2011;29:1137–1148.
24. Kavanagh H, Mahon BP. Allogeneic mes-enchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy 2011;66:523–531.
25. Lee SH, Jang AS, Kwon JH et al. Mesen-chymal stem cell transfer suppresses airway remodeling in a toluene diisocyanate-induced murineasthmamodel. AllergyAsthmaImmunol Res 2011;3:205–211.
26. Ou-Yang HF, Huang Y, Hu XB et al. Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesen-chymal stem cells. Exp Biol Med (Maywood) 2011;236:1461–1467.
27. Ionescu LI, Alphonse RS, Arizmendi N et al. Airway delivery of soluble factors from plastic-adherent bone marrow cells prevents murine asthma. Am J Respir Cell Mol Biol 2012;46:207–216.
28. 28 Lathrop MJ, Brooks EM, Bonenfant NR et al. Mesenchymal stromal cells mediate As- pergillus hyphal extract-induced allergic airway inflammation by inhibitionoftheTh17 signaling pathway. Stem Cells Translational Medicine 2014;3:194–205.
29. Allard JB, Poynter ME, Marr KA et al. As-pergillus fumigatus generates an enhanced Th2-biasedimmuneresponseinmicewithdefec-tive cystic fibrosis transmembrane conductance regulator. J Immunol 2006;177:5186–5194.
30. Allard JB, Rinaldi L, Wargo MJ et al. Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products. Eur J Immunol 2009;39: 776–788.
31. Kim ES, Chang YS, Choi SJ et al. Intratra-cheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice. Respir Res 2011;12:108.
32. Sun J, Han ZB, Liao W et al. Intrapulmo-nary delivery of human umbilical cord mesen-chymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti-and pro-inflammatory factors. Cell Physiol Bio-chem 2011;27:587–596.
33. Chang YS, Choi SJ, Sung DK et al. Intratra-cheal transplantation of human umbilical cord blood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Cell Transplant 2011;20:1843–1854.
34. Pierro M, Ionescu L, Montemurro T et al. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cellsinlung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 2013;68: 475–484.
35. Pati S, Gerber M, Menge TD et al. Bone marrowderived mesenchymalstem cellsinhibit inflammationandpreservevascularendothelial integrity in the lungs after hemorrhagic shock. PLoS One 2011;6:e25171.
36. Peister A, Mellad JA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103: 1662–1668.
37. About PACT. Available at https://secure.emmes.com/pactweb/Facilities. Accessed January 14, 2015.
38. Reed W, Noga SJ, Gee AP et al. Production Assistance for Cellular Therapies (PACT): Four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies. Transfusion 2009;49: 786–796.
39. Schuessler TF, Bates JH. A computer-controlledresearchventilator for smallanimals: Design and evaluation. IEEE Trans Biomed Eng 1995;42:860–866.
40. Gomes RF, Shardonofsky F, Eidelman DH et al. Respiratory mechanics and lung development in the rat from early age to adulthood. J Appl Physiol (1985) 2001;90:1631–1638.
41. Asmussen S, Ito H, Traber DL et al. Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia. Thorax 2014;69:819–825.
42. Amos PJ, Kapur SK, Stapor PC et al. Human adipose-derived stromal cells accelerate diabetic wound healing: Impact of cell formulation and delivery. Tissue Eng Part A 2010;16: 1595–1606.
43. Moll G, Rasmusson-Duprez I, von Bahr L et al. Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells 2012;30:1565–1574.
44. Jitschin R, Mougiakakos D, Von Bahr L et al. Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation. Stem Cells 2013;31:1715–1725.
45. François M, Romieu-Mourez R, Li M et al. Human MSC suppression correlates with cyto-kine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 2012;20:187–195.
46. Lim R, Milton P, Murphy SV et al. Human mesenchymal stem cells reduce lung injury in immunocompromised mice but not in immunocompetent mice. Respiration 2013; 85:332–341.
47. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but notTh1 murine helperTlymphocyte clones. J Immunol 1988;140:4245–4252.
48. Parronchi P, De Carli M, Manetti R et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cyto-lytic potentialbyTh1orTh2humanTcellclones. J Immunol 1992;149:2977–2983.